Methodology, efficacy and safety of fecal microbiota transplant in treating inflammatory bowel disease
MetadataShow full item record
Fecal microbiota transplantation (FMT), as an emerging therapy, can be used to treat microbiota related diseases. Progresses in donor screening, washed microbiota preparation, microbiota delivery routes, clinical administrative strategies, and long-term safety are moving FMT forward. Increasing clinical studies, especially those randomized controlled trials about ulcerative colitis and pilot real-word studies about serious inflammatory bowel disease (IBD), have been conducted. This review presents the latest findings about the efficacy, safety and methodology of FMT in treating IBD.
Palabras claveWashed microbiota transplantation; Transendoscopic enteral tubing; Ulcerative colitis; Crohn's disease; Adverse event; Safety
Link to resourcehttps://doi.org/10.1016/j.medmic.2020.100028
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.